Dialysis Phosphate Binder Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Dialysis Phosphate Binder
When kidneys aren't working properly, they lose their ability to filter waste products from the blood, including excess phosphate. This condition, known as hyperphosphatemia, is particularly common in people with advanced chronic kidney disease (CKD) and those undergoing dialysis. Left unchecked, high phosphate levels can lead to serious health complications, such as weakened bones, joint pain, and an increased risk of cardiovascular disease, which is a major concern for dialysis patients.
To combat hyperphosphatemia, healthcare providers typically prescribe a class of medications called phosphate binders. These medications work by attaching to phosphate in the food you eat, preventing it from being absorbed into your bloodstream. Instead, the bound phosphate is then passed out of the body in your stool. This helps to keep your blood phosphate levels within a healthy range.
There are several types of phosphate binders available, each with its own mechanism and considerations. Common examples include calcium-based binders like calcium acetate (e.g., PhosLo), and non-calcium based binders such as sevelamer carbonate (e.g., Renvela, Renagel), lanthanum carbonate (e.g., Fosrenol), sucroferric oxyhydroxide (e.g., Velphoro), and ferric citrate (e.g., Auryxia). Your doctor will determine which binder is best suited for your specific needs, often in conjunction with dietary modifications to limit high-phosphate foods.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.